Sale!

UCSF CME: 39th Annual Advances in Heart Disease 2022 (Videos)

Name: UCSF CME: 39th Annual Advances in Heart Disease 2022 (Videos)
SKU: 90078
Availability: InStock

Original price was: $550.Current price is: $70.

5 Videos + 28 PDFs , 4.44 GB

Categories: Cardiology, ‎English, Videos/Audios Tag: UCSF CME: 39th Annual Advances in Heart Disease 2022 (Videos)

Description
Reviews (0)

Our 39th annual course will again strive to present topics that highlight new evidence-based medicine findings reported within the last one to two years that impact clinical practice. These will range across a variety of cardiologic subspecialty interests including heart failure, arrhythmias, cardiac surgery, gene therapy, aortic diseases, prevention and artificial intelligence.

Our faculty will include a distinguished group of visiting academicians from North America together with outstanding teachers and clinicians from the University of California, San Francisco.

All sessions will be recorded and made available to participants for online viewing 30 days post course.

TARGET AUDIENCE
This course is intended for cardiovascular specialists, practicing cardiologists, internists, family physicians, cardiovascular

Objectives:

Providing the best management of coronary heart disease, hypertension, lipid disorders, diabetes, systolic and diastolic heart failure, atrial fibrillation and flutter, STEMI and non-STEMI, thromboembolic disease
Refining considerations for atrial fibrillation, atrial flutter, and ventricular tachycardia ablation
Applying the best considerations of surgical revascularization or percutaneous intervention for management of coronary heart disease
Recognizing risk stratification of cardiovascular disease
Optimizing the management of ascending thoracic aorta disease
Optimizing the management of pulmonary embolism
Recognizing the role of cardiac surgery in the management of endocarditis
Recognizing the genetic basis of cardiovascular diseases
Recognizing the importance of deep empathy in patient interactions
Recognizing that pathophysiology of diseases and treatment options differ among racial and ethnic groups
Optimizing the management of cardiac amyloidosis
Recognizing the connection between the mind and the heart
Recognizing the role of air pollution as a risk factor for cardiovascular diseases

Course Outline:

Friday, December 2, 2022
7:00 a.m.	Registration and Continental Breakfast
8:10 a.m.	Welcome and Symposium Overview	Peter Ganz, MD
Session: Frontiers in Cardiology: Genetics, Artificial Intelligence and Deep Empathy		Chair: Priscilla Hsue, MD
8:15 a.m.	The Mind-Heart Connection: Stress and Trauma as Cardiovascular Risk Factors	Ahmed Tawakol, MD
8:55 a.m.	Artificial Intelligence in Cardiology	Geoff Tison, MD, MPH
9:35 a.m.	Ascending Thoracic Aortic Aneurysms: Evaluation, Management and Genetic Testing	Lisa Wilsbacher, MD, PhD
10:15 a.m.	Coffee Break
10:30 a.m.	Update on Transthyretin Amyloidosis	Mandar Aras, MD, PhD
11:10 a.m.	Gene Targeting for Cardiometabolic Diseases – Where are We?	John Chorba, MD
11:50 a.m.	Elliot Rapaport Keynote Lecture: High Performance with Deep Empathy Medicine	Eric Topol, MD
12:40 a.m.	Lunch (on Your Own)
Session: State-of-the-Art: Cardiovascular Interventions		Chair: Lucas Zier, MD, MS
2:00 p.m.	New Approaches to Pulmonary Embolism	Gregory Piazza, MD, MS
2:40 p.m.	Physiological Assessment of Coronary Stenosis Severity by CT Angiography and in the Cath Lab	William Fearon, MD
3:20 p.m.	Expanding Options in the Management of Endocarditis	Amy Fiedler, MD, MS
		Ann Bolger, MD
4:00 p.m.	Coffee Break
4:15 p.m.	Surgical Approaches to Advanced Heart Failure	Jason Smith, MD
4:55 p.m.	Revascularization in Stable Coronary Disease: Sorting through the Evidence	Jeffrey Zimmet, MD, PhD
5:35 p.m.	Adjourn
Saturday, December 3, 2022
7:30 a.m.	Continental Breakfast
8:05 a.m.	Announcements	Peter Ganz, MD
Session: Advances and Controversies in Electrophysiology		Chair: Nora Goldschlager, MD
8:10 a.m.	Defining Sudden Cardiac Death in 2022	Zian Tseng, MD, MAS
8:50 a.m.	ECG Findings Suggesting High Arrhythmic Risk	Melvin Scheinman, MD
9:30 a.m.	Debate: AFib Ablation Should be First Line Therapy in Patients with Symptomatic AFib	Adam Lee, MD
		Tommy Dewland, MD
10:10 a.m.	Coffee Break
10:25 a.m.	Advances in Cardiac Imaging for Arrhythmia Etiology, Prognosis and Therapy	Edward Gerstenfeld, MD, MS
11:05 a.m.	The Effect of Alcohol, Exercise and Lifestyle on Atrial Fibrillation	Gregory Marcus, MD, MAS
11:45 a.m.	Interventions for Novel/Genetic Arrhythmias	Vasanth Vedantham, MD, PhD
12:25 p.m	Debate: Prophylactic Primary Prevention ICD in Dilated Cardiomyopathy with Heart Failure	Byron Lee, MD, MS
		Joshua Moss, MD, MS
1:05 p.m.	Lunch (on your own)
Session: Managing Heart Failure		Chair: Jonathan Davis, MD, MPHS
2:20 p.m.	Cardiogenic Shock	Jaya Mallidi, MD
3:00 p.m.	New Heart Failure Guidelines for HFrEF	Jonathan Davis, MD, MPHS
3:40 p.m.	New Heart Failure Guidelines for HFpEF	Jonathan Davis, MD, MPHS
4:20 p.m.	Coffee Break
4:35 p.m.	Polypharmacy and Medication Costs for Guideline Directed Medical Therapy for HFrEF	Anusha McNamara, PharmD
		Rose Pavlakos, PharmD
5:15 p.m.	Remote Monitoring of Patients with	Liviu Klein, MD, MS
	Cardiovascular Diseases
5:55 p.m.	Adjourn
Sunday, December 4, 2022
7:30 a.m.	Continental Breakfast
8:00 a.m.	Announcements	Peter Ganz, MD
Session: Managing Cardiovascular Risk		Chair: Binh An P. Phan, MD
8:05 a.m.	The Effect of Salt and Salt Substitutes Consumption on Clinical Outcomes in Hypertension and Heart Failure	Michael Crawford, MD
8:45 a.m.	Managing Cardiovascular Risk in the Elderly	Carlin Long, MD
9:25 a.m.	Current Cholesterol Guidelines: Controversies and Agreements	Peter Ganz, MD
10:05 a.m.	Where Are We with Non-Statin Lipid Modifying Therapy?	Jorge Plutzky, MD
10:45 a.m.	Management of Cardiovascular Risk and Chronic Kidney Disease Progression with Patients with Diabetes	Lisa Murphy, MD, PhD
11:25 a.m.	Impact of Air Pollution on Cardiovascular	Karol Watson, MD, PhD
	Outcomes
12:05 p.m.	Adjourn